KAT2A and breast cancer: Conversely, GCN5 depletion or inhibition of its HAT activity has been shown to induce apoptosis and reduce viability of Burkitt lymphoma cells as well as lead to increased sensitivity of ER-positive breast cancer cells for tamoxifen (65, 71).